glp-1 news 2025 november Pipeline Update: August - Prime Therapeutics Novo cuts GLP-1 prices 70%,

(2021b)

Emerging imaging studies suggest tirzepatide may improve muscle quality , reducing fat infiltration within muscle tissue even as overall lean mass decreasesindicating a potential improvement in muscle composition rather than functional loss

Notably, a 2020 clinical trial involving patients with nonalcoholic steatohepatitis (NASH) revealed a 15% incidence of tumors (benign, malignant, or unspecified) (35/239) among those administered semaglutide, compared to 8% (6/80) in the control group [108]

With the right knowledge, strategies, and support, achieving healthy weight loss while maintaining muscle mass is an attainable goal

Take vitamin D with a meal containing fat for optimal absorption, fat-soluble vitamins need dietary fat as a carrier

Diabetic nephropathy: An FDA decision for semaglutide (Ozempic) for the prevention of diabetic nephropathy in adults with T2DM and cardiovascular disease (CVD) is expected in January 2025